Procter & Gamble Q4 and Fiscal Year 2025 Results

The Procter & Gamble Company reported its fourth quarter and fiscal year 2025 results. For Q4, net sales increased by 2%, organic sales grew by 2%, diluted EPS rose by 17%, and core EPS increased by 6%. For the full fiscal year, net sales remained flat, organic sales grew by 2%, diluted EPS increased by 8%, and core EPS rose by 4%. The company highlighted its strong cash return to shareholders, with over $16 billion returned via dividends and share repurchases. P&G also announced plans for fiscal year 2026, expecting organic sales growth in the range of flat to up 4% and core EPS growth in the range of flat to up 4%. The company continues to focus on its integrated strategy of product portfolio superiority, productivity, and constructive disruption to drive sustainable growth.